Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Recurrence Rate of Cystoid Macular Edema with Topical Dorzolamide Treatment and Its Risk Factors in Retinitis Pigmentosa.
RETINA ( IF 3.3 ) Pub Date : 2021-08-12 , DOI: 10.1097/iae.0000000000003286 Shotaro Shimokawa 1 , Yusuke Murakami 1 , Kohta Fujiwara 1 , Jun Funatsu 1 , Shunji Nakatake 1 , Yoshito Koyanagi 1 , Masato Akiyama 1 , Noriko Yoshida 2 , Atsunobu Takeda 1 , Yasuhiro Ikeda 3 , Koh-Hei Sonoda 1
RETINA ( IF 3.3 ) Pub Date : 2021-08-12 , DOI: 10.1097/iae.0000000000003286 Shotaro Shimokawa 1 , Yusuke Murakami 1 , Kohta Fujiwara 1 , Jun Funatsu 1 , Shunji Nakatake 1 , Yoshito Koyanagi 1 , Masato Akiyama 1 , Noriko Yoshida 2 , Atsunobu Takeda 1 , Yasuhiro Ikeda 3 , Koh-Hei Sonoda 1
Affiliation
To investigate the rate of the recurrence of cystoid macular edema (CME) secondary to retinitis pigmentosa (RP) after the initiation of topical dorzolamide and the recurrence risk factors.
中文翻译：
局部多佐胺治疗黄斑囊样水肿的复发率及其在色素性视网膜炎中的危险因素。
研究开始局部使用多佐胺后继发于视网膜色素变性（RP）的黄斑囊样水肿（CME）的复发率和复发危险因素。
更新日期：2021-08-12
中文翻译：
局部多佐胺治疗黄斑囊样水肿的复发率及其在色素性视网膜炎中的危险因素。
研究开始局部使用多佐胺后继发于视网膜色素变性（RP）的黄斑囊样水肿（CME）的复发率和复发危险因素。
京公网安备 11010802027423号